International Journal of Infectious Diseases
Volume 13, Issue 3 , Pages 369-373 , May 2009

Crimean-Congo hemorrhagic fever: does it involve the heart?

  • Aynur Engin

      Affiliations

    • Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 346 2581084; fax: +90 346 2581305.
  • ,
  • Mehmet Birhan Yilmaz

      Affiliations

    • Department of Cardiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Nazif Elaldi

      Affiliations

    • Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Alim Erdem

      Affiliations

    • Department of Cardiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Kenan Yalta

      Affiliations

    • Department of Cardiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Izzet Tandogan

      Affiliations

    • Department of Cardiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Safak Kaya

      Affiliations

    • Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Mehmet Bakir

      Affiliations

    • Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey
  • ,
  • Ilyas Dokmetas

      Affiliations

    • Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University, School of Medicine, 58140 Sivas, Turkey

Received 12 January 2008 ,Revised 18 July 2008 ,Accepted 21 July 2008.

References 

  1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145–160
  2. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203–214
  3. Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med. 1997;121:839–846
  4. Bray M. Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol. 2005;17:399–403
  5. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11(Suppl 4):S794–800
  6. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006;12:551–554
  7. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo haemorrhagic fever. Curr Opin Infect Dis. 2007;20:495–500
  8. Joubert JR, King JB, Rossouw DJ, Cooper R. A nosocomial outbreak of Crimean- Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S Afr Med J. 1985;68:722–728
  9. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32:2416–2421
  10. Savoia MC, Oxman MN. Myocarditis and pericarditis. In:  Mandell GL,  Bennett JE,  Dolin R editor. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005;p. 1052–1070
  11. Wali JP, Biswas A, Chandra S, Malhotra A, Aggarwal P, Handa R, et al. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol. 1998;64:31–36
  12. Saggioro FP, Rossi MA, Duarte MI, Martin CC, Alves VA, Moreli ML, et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis. 2007;195:1541–1549
  13. Oubiña JR, Milei J, Bolomo NJ, Molindo A, Carballal G. Experimental Argentine hemorrhagic fever: myocardial involvement in Cebus monkey. J Med Primatol. 1986;15:391–397
  14. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad Med J. 2001;77:4–10
  15. Obeyesekere I, Hermon Y. Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever). Br Heart J. 1972;34:821–827
  16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography; European Society of Cardiology Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108
  17. Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med. 2004;10(Suppl 12):S110–S121
  18. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941–944
  19. Nagaratnam N, Siripala K, de Silva N. Arbovirus (dengue type) as a cause of acute myocarditis and pericarditis. Br Heart J. 1973;35:204–206
  20. Pinamonti B, Alberti E, Cigalotto A, Dreas L, Salvi A, Silvestri F, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285–291
  21. Qian C, Jahrling PB, Peters CJ, Liu CT. Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab Anim Sci. 1994;44:600–607
  22. Peters CJ, Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med. 2002;30(5 Suppl):S268–S273

PII: S1201-9712(08)01492-6

doi: 10.1016/j.ijid.2008.07.019

International Journal of Infectious Diseases
Volume 13, Issue 3 , Pages 369-373 , May 2009